Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 681

2.

SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.

Yusa S, Catina TL, Campbell KS.

J Immunol. 2002 May 15;168(10):5047-57.

PMID:
11994457
[PubMed - indexed for MEDLINE]
Free Article
3.

KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).

Yusa S, Catina TL, Campbell KS.

J Immunol. 2004 Jun 15;172(12):7385-92.

PMID:
15187115
[PubMed - indexed for MEDLINE]
Free Article
4.

Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.

Bruhns P, Marchetti P, Fridman WH, Vivier E, Daëron M.

J Immunol. 1999 Mar 15;162(6):3168-75.

PMID:
10092767
[PubMed - indexed for MEDLINE]
Free Article
5.

Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.

Burshtyn DN, Lam AS, Weston M, Gupta N, Warmerdam PA, Long EO.

J Immunol. 1999 Jan 15;162(2):897-902.

PMID:
9916713
[PubMed - indexed for MEDLINE]
Free Article
6.

Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.

Lowin-Kropf B, Kunz B, Beermann F, Held W.

J Immunol. 2000 Aug 1;165(3):1314-21.

PMID:
10903732
[PubMed - indexed for MEDLINE]
Free Article
7.

KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.

Faure M, Long EO.

J Immunol. 2002 Jun 15;168(12):6208-14.

PMID:
12055234
[PubMed - indexed for MEDLINE]
Free Article
8.
9.
10.

Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.

Wang LL, Blasioli J, Plas DR, Thomas ML, Yokoyama WM.

J Immunol. 1999 Feb 1;162(3):1318-23.

PMID:
9973385
[PubMed - indexed for MEDLINE]
Free Article
11.

Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.

Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet JP, Abraham RT, Leibson PJ.

Immunity. 1996 Dec;5(6):629-38.

PMID:
8986721
[PubMed - indexed for MEDLINE]
Free Article
14.
15.
16.

Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases.

Gupta N, Scharenberg AM, Burshtyn DN, Wagtmann N, Lioubin MN, Rohrschneider LR, Kinet JP, Long EO.

J Exp Med. 1997 Aug 4;186(3):473-8.

PMID:
9236201
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).

Long EO, Barber DF, Burshtyn DN, Faure M, Peterson M, Rajagopalan S, Renard V, Sandusky M, Stebbins CC, Wagtmann N, Watzl C.

Immunol Rev. 2001 Jun;181:223-33. Review.

PMID:
11513144
[PubMed - indexed for MEDLINE]
18.

KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity.

Han Y, Zhang M, Li N, Chen T, Zhang Y, Wan T, Cao X.

Blood. 2004 Nov 1;104(9):2858-66. Epub 2004 Jul 6.

PMID:
15238421
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk